Therma Bright (TSE:THRM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Therma Bright’s distribution partners in the U.S. have achieved rapid Medicare and Medicaid reimbursement approvals for their Venowave VW5 device in under 60 days. This achievement is expected to accelerate commercialization efforts as it impresses medical networks and sets a roadmap for increased sales.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.